A meta‐analysis of “hospital in the home”-Reference-Cited by-同舟云学术

A meta‐analysis of “hospital in the home”

Published:2013-03 Issue:4 Volume:198 Page:195-196
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Caplan Gideon A¹²

Affiliation:

1. Post Acute Care Services, Prince of Wales Hospital, Sydney, NSW.

2. Prince of Wales Clinical School, University of New South Wales, Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja12.11841

Reference5 articles.

1. A meta‐analysis of “hospital in the home”

2. Post acute care: Can hospitals do better with less?

3. Acute stroke unit care combined with early supported discharge. Long-term effects on quality of life. A randomized controlled trial

4. Report of a joint working party of the Royal College of Physicians of London and the British Cardiac Society;The care of the patient with coronary heart disease;J R Coll Physicians Lond,1975

5. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction;Teo KK;JAMA,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proportion of medical admissions that may be hospitalised at home and their service utilisation patterns: a single-centre, descriptive retrospective cohort study in Singapore;BMJ Open;2023-10

2. Factors impacting hospital avoidance program utilisation in the care of acutely unwell residential aged care facility residents;BMC Health Services Research;2021-06-24

3. Comparison of Hospital-at-Home models: a systematic review of reviews;BMJ Open;2021-01

4. Models of care that avoid or improve transitions to hospital services for residential aged care facility residents: An integrative review;Geriatric Nursing;2020-07

5. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial;The Lancet Infectious Diseases;2019-05